Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Use of CIP (Clean-In-Place) Systems in Injectable Manufacturing – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Use of CIP (Clean-In-Place) Systems in Injectable Manufacturing – V 2.0

Standard Operating Procedure for Use of CIP (Clean-In-Place) Systems in Injectable Manufacturing


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/127/2025
Supersedes SOP/SIM/127/2022
Page No. Page 1 of 15
Issue Date 24/06/2025
Effective Date 26/06/2025
Review Date 24/06/2026

1. Purpose

To describe the validated procedure for the operation of Clean-In-Place (CIP) systems for cleaning vessels, transfer pipelines, filters, and other equipment used in sterile injectable manufacturing. This SOP ensures consistency, hygiene, and

compliance with GMP.

2. Scope

This procedure is applicable to all CIP systems installed in the sterile injectable manufacturing area for the cleaning of solution preparation tanks, transfer lines, holding vessels, and related piping components.

3. Responsibilities

  • Manufacturing Operator: Operates and monitors CIP cycles.
  • Manufacturing Supervisor: Ensures adherence to procedure and reviews logs.
  • Quality Assurance: Verifies cleaning effectiveness and approves records.
  • Engineering Department: Maintains CIP system equipment and performs calibration.
See also  Sterile Injectable Manufacturing: SOP for Verification of Batch Numbers during Packaging - V 2.0

4. Accountability

Production Head and QA Head are accountable for ensuring SOP compliance and effectiveness of the CIP cleaning cycle.

5. Procedure

5.1 Pre-Cleaning Checks

  1. Ensure the CIP system is connected correctly to the equipment to be cleaned.
  2. Verify availability of approved cleaning agents and proper concentration.
  3. Ensure equipment is free from gross contamination before initiating CIP.
  4. Record the pre-cleaning status in the CIP Pre-Cleaning Checklist (Annexure-1).

5.2 CIP Cycle Overview

  1. The standard CIP cycle consists of the following steps:
    • Initial Rinse (Water for Injection – WFI)
    • Alkaline Wash with Detergent
    • Intermediate Rinse (Purified Water)
    • Acid Rinse (if applicable)
    • Final Rinse (WFI)
    • Drying (Air/Nitrogen Flush if validated)

5.3 Operating Instructions

  1. Turn on the CIP system and set the parameters per the validated CIP recipe loaded in the HMI/SCADA.
  2. Verify temperature and flow rate sensors are calibrated and operational.
  3. Start the CIP cycle and monitor:
    • Flow rate and pressure (must meet validated specifications)
    • Temperature (e.g., 80°C for hot WFI rinse)
    • Detergent concentration (verified via titration)
    • Cycle timing and sequencing
  4. Document all values in the CIP Execution Log (Annexure-2).
See also  Packaging: SOP for Visual Inspection of Packed Injectable Products - V 2.0

5.4 Post-Cleaning Verification

  1. Visually inspect equipment for residue, staining, or pooling of cleaning agents.
  2. Collect rinse water samples and send to QC for:
    • TOC (Total Organic Carbon)
    • Conductivity
    • Microbial Testing
  3. Confirm cleanliness before use in manufacturing. Fill Cleaning Approval Form (Annexure-3).

5.5 Special Considerations

  1. Never modify the validated cycle without re-approval.
  2. Re-validate the CIP cycle after any significant system changes or new equipment integration.

5.6 Cleaning Frequency

  1. Perform CIP after every batch or as per the cleaning schedule.
  2. Record all cleaning activities in the Cleaning Schedule Log.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • CIP: Clean-In-Place
  • WFI: Water for Injection
  • TOC: Total Organic Carbon
  • QC: Quality Control
  • HMI: Human Machine Interface

7. Documents

  1. CIP Pre-Cleaning Checklist – Annexure-1
  2. CIP Execution Log – Annexure-2
  3. Cleaning Approval Form – Annexure-3

8. References

  • WHO TRS 986 – GMP for Pharmaceutical Products
  • 21 CFR Part 211 – US FDA cGMP
  • ISPE Baseline Guide for Cleaning Validation
See also  Sterile Injectable Manufacturing: SOP for Dispensing Materials for Subcutaneous Injections - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: CIP Pre-Cleaning Checklist

Checklist Item Status Checked By Date
Line Clearance Completed Rajesh Kumar 24/06/2025
Cleaning Agent Available Yes Sunita Reddy 24/06/2025

Annexure-2: CIP Execution Log

Parameter Set Value Observed Value Checked By Date
Rinse Temp (WFI) 80°C 79.5°C Ajay Verma 24/06/2025
Detergent Flow Rate 100 L/min 102 L/min Ajay Verma 24/06/2025

Annexure-3: Cleaning Approval Form

Equipment ID Cleaned On Inspected By Approved By Date
CIP-002 24/06/2025 Ravi Sharma QA Officer 24/06/2025

Revision History

Revision Date Revision No. Details Reason Approved By
15/02/2022 1.0 Initial SOP Released New Installation QA Head
24/06/2025 2.0 Updated Cycle Parameters & Documentation Flow Annual Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Elixir Department: SOP for Agitation Speed Adjustment Based on Batch Size – V 2.0
Next Post: Analytical Method Development: SOP for Validation Protocol Preparation – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version